内科理论与实践 ›› 2023, Vol. 18 ›› Issue (05): 359-362.doi: 10.16138/j.1673-6087.2023.05.011
收稿日期:
2023-03-01
出版日期:
2023-10-30
发布日期:
2024-01-25
通讯作者:
冯文焕
E-mail:fengwh501@163.com
基金资助:
HUANG Yuanhao1, SHEN Yuanyuan1, HAN Tao1, ZHANG Bingqing2, FENG Wenhuan1()
Received:
2023-03-01
Online:
2023-10-30
Published:
2024-01-25
Contact:
FENG Wenhuan
E-mail:fengwh501@163.com
中图分类号:
黄元灏, 沈媛媛, 韩涛, 张冰青, 冯文焕. 葡萄糖在目标范围内时间与糖尿病慢性并发症[J]. 内科理论与实践, 2023, 18(05): 359-362.
HUANG Yuanhao, SHEN Yuanyuan, HAN Tao, ZHANG Bingqing, FENG Wenhuan. Glucose in the target range of time is associated with chronic complications of diabetes[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(05): 359-362.
[1] | Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997. |
[2] |
Gabbay MAL, Rodacki M, Calliari LE, et al. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes[J]. Diabetol Metab Syndr, 2020, 12: 22.
doi: 10.1186/s13098-020-00529-z pmid: 32190124 |
[3] | 中华医学会糖尿病学分会. 中国血糖监测临床应用指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(10): 936-948. |
[4] |
Runge AS, Kennedy L, Brown AS, et al. Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes[J]. Clin Diabetes, 2018, 36(2): 112-119.
doi: 10.2337/cd17-0094 URL |
[5] | 王诗佳. 基于子午流注理论探讨甲状腺功能亢进症患者动态血糖谱波动特点[D]. 辽宁中医药大学, 2022. |
[6] |
Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile(AGP)[J]. Diabetes Technol Ther, 2013, 15(3):198-211.
doi: 10.1089/dia.2013.0051 URL |
[7] |
Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring[J]. Diabetes Care, 2017, 40(12): 1631-1640.
doi: 10.2337/dc17-1600 pmid: 29162583 |
[8] |
Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range[J]. Diabetes Care, 2019, 42(8): 1593-1603.
doi: 10.2337/dci19-0028 pmid: 31177185 |
[9] | 冯中原, 石勇铨. 评估血糖控制的新指标: 葡萄糖在目标范围内时间[J]. 现代实用医学, 2020, 32(9): 1023-1025. |
[10] | 隽娟, 杨慧霞. 美国糖尿病学会2023年“妊娠合并糖尿病诊治指南”解读[J]. 中华围产医学杂志, 2023, 26(4): 265-269. |
[11] |
Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care, 2018, 41(11): 2370-2376.
doi: 10.2337/dc18-1131 pmid: 30201847 |
[12] |
Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials[J]. Diabetes Care, 2019, 42(3): 400-405.
doi: 10.2337/dc18-1444 pmid: 30352896 |
[13] | 邝嘉敏, 顾炽昌, 梁勇前. 血糖控制目标范围内时间与糖尿病视网膜病变的相关性分析[J]. 广州医科大学学报, 2021, 49(4): 99-102. |
[14] | 余萍萍. TIR与2型糖尿病患者尿白蛋白水平的相关性研究[D]. 河北医科大学, 2020. |
[15] |
Mayeda L, Katz R, Ahmad I, et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e000991.
doi: 10.1136/bmjdrc-2019-000991 URL |
[16] | 马雅琼. TIR与2型糖尿病周围神经病变的相关性研究[D]. 河北医科大学, 2020. |
[17] | Guo Q, Zang P, Xu S, et al. Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese type 2 diabetes[J]. J Diabetes Res, 2020, 2020: 5817074. |
[18] | 王迪文, 胡飞, 周路路, 等. 2型糖尿病患者并发大血管病变的影响因素分析[J]. 淮海医药, 2022, 40(4): 354-356. |
[19] | 王丹钰, 刘凯坤, 张云, 等. 2型糖尿病患者葡萄糖目标范围内时间与冠状动脉病变严重程度的相关性研究[J]. 中华内分泌代谢杂志, 2021, 37(11): 973-978. |
[20] | 陈中国, 朱晓丽, 万宇婷, 等. 颈动脉内膜中层厚度与冠心病的相关性分析[J]. 中华介入放射学电子杂志, 2019, 7(1):31-34. |
[21] |
Lu J, Ma X, Shen Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes[J]. Diabetes Technol Ther, 2020, 22(2): 72-78.
doi: 10.1089/dia.2019.0251 URL |
[22] | 任彩琴. 2型糖尿病患者葡萄糖目标范围内时间与颈动脉内膜中层厚度的相关性分析[D]. 兰州大学, 2021. |
[23] |
Wang Y, Lu J, Shen Y, et al. Association of time in range with lower extremity atherosclerotic disease in type 2 diabetes mellitus: a prospective cohort study[J]. Endocrine, 2022, 76(3): 593-600.
doi: 10.1007/s12020-022-03038-3 |
[24] | 言雪佳, 孙红, 杜宣, 等. 2型糖尿病患者持续葡萄糖监测指标与颈动脉粥样硬化的关系[J]. 山东医药, 2020, 60(32):47-50. |
[25] | American Diabetes Association. 7 diabetes technology: standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44 Suppl 1: S85-S99. |
[26] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. |
[27] |
Ang E, Lee ZX, Moore S, et al. Flash glucose monitoring (FGM): a clinical review on glycaemic outcomes and impact on quality of life[J]. J Diabetes Complications, 2020, 34(6):107559.
doi: 10.1016/j.jdiacomp.2020.107559 URL |
[28] |
Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes[J]. Diabetes Technol Ther, 2019, 21(2): 81-85.
doi: 10.1089/dia.2018.0310 URL |
[29] |
Advani A. Positioning time in range in diabetes management[J]. Diabetologia, 2020, 63(2): 242-252.
doi: 10.1007/s00125-019-05027-0 pmid: 31701199 |
[1] | 刘陈肖笑, 简扬, 张演基, 等.
基于抗生素骨水泥的糖尿病足溃疡治疗策略研究进展
[J]. 组织工程与重建外科杂志, 2023, 19(6): 591-. |
[2] | 林崴仪, 戈成旺, 唐枭伟, 等. 阿克曼嗜黏液菌外膜蛋白 1100 促进糖尿病大鼠创面愈合 [J]. 组织工程与重建外科杂志, 2023, 19(4): 358-. |
[3] | 王伟铭. 糖尿病肾脏疾病肾性贫血认识与管理中国专家共识(2023年版)解读[J]. 内科理论与实践, 2023, 18(03): 137-140. |
[4] | 毕礼明, 王朝晖. 糖尿病肾病发病机制研究进展[J]. 内科理论与实践, 2023, 18(03): 201-205. |
[5] | 张小月, 王伟铭. 盐皮质激素受体拮抗剂在糖尿病肾病治疗中的研究进展[J]. 内科理论与实践, 2023, 18(03): 206-210. |
[6] | 高玉莲, 冯耘, 倪磊. 糖尿病人群中耐药革兰阴性菌血流感染的研究进展[J]. 内科理论与实践, 2023, 18(02): 124-127. |
[7] | 张梦潇, 韦晓, 张少红, 陈国芳, 刘超. 生长分化因子15:减重治疗的新靶点[J]. 内科理论与实践, 2023, 18(02): 128-130. |
[8] | 张梦潇, 孙烁烁, 韦晓, 张少红, 陈国芳, 刘超. 生酮饮食诱导db/db小鼠肝脏脂肪沉积[J]. 内科理论与实践, 2023, 18(01): 56-63. |
[9] | 中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12. |
[10] | 卜凡玉 郭晓峰 徐鹏 王进 薛明宇 潘筱云. 抗生素骨水泥联合其他综合干预措施治疗糖尿病足骨髓炎[J]. 组织工程与重建外科杂志, 2022, 18(4): 328-. |
[11] | 缪雅, 刘丽丽, 侯田志超, 严青华, 庞怡, 吴春晓, 程旻娜, 施燕, 黎衍云, 田景琰. 上海糖尿病前期人群恶性肿瘤发病风险分析[J]. 内科理论与实践, 2022, 17(06): 435-440. |
[12] | 阮铭, 侯田志超, 王海燕, 黎衍云, 周冰心, 包超慧, 秦洁洁, 王宇光, 方海, 朱伟嵘, 田景琰. 糖尿病前期“治未病”的几何深度学习与计算医学研究展望[J]. 内科理论与实践, 2022, 17(06): 475-481. |
[13] | 秦雪, 郭华, 张云云, 崔小川. C1q肿瘤坏死因子相关蛋白3与代谢相关疾病的研究进展[J]. 内科理论与实践, 2022, 17(06): 482-485. |
[14] | 许晴, 邵慧英, 陈帅, 全进伟, 周清芬, 王敏慧. 延续健康教育和指导对干预2型糖尿病患者冠状动脉斑块进展的影响[J]. 内科理论与实践, 2022, 17(04): 330-333. |
[15] | 高晶晶, 高艳虹. 早发2型糖尿病流行病学、临床特征及病因机制的研究进展[J]. 内科理论与实践, 2022, 17(04): 344-348. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||